نتایج جستجو برای: واکسن mmr

تعداد نتایج: 5388  

Journal: :Cell 2000
Erick Denamur Guillaume Lecointre Pierre Darlu Olivier Tenaillon Cécile Acquaviva Chalom Sayada Ivana Sunjevaric Rodney Rothstein Jacques Elion François Taddei Miroslav Radman Ivan Matic

Mutation and subsequent recombination events create genetic diversity, which is subjected to natural selection. Bacterial mismatch repair (MMR) deficient mutants, exhibiting high mutation and homologous recombination rates, are frequently found in natural populations. Therefore, we have explored the possibility that MMR deficiency emerging in nature has left some "imprint" in the sequence of ba...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Nicola J Curtin Lan-Zhen Wang Anthie Yiakouvaki Suzanne Kyle Christine A Arris Stacie Canan-Koch Stephen E Webber Barbara W Durkacz Hilary A Calvert Zdenek Hostomsky David R Newell

PURPOSE Mismatch repair (MMR) deficiency confers resistance to temozolomide, a clinically active DNA-methylating agent. The purpose of the current study was to investigate the reversal mechanism of temozolomide resistance by the potent novel poly(ADP-ribose) polymerase (PARP)-1 inhibitor, AG14361, in MMR-proficient and -deficient cells. EXPERIMENTAL DESIGN The effects of AG14361, in compariso...

2011
Katrina Brown Graham Fraser Mary Ramsay Ruth Shanley Noel Cowley Johan van Wijgerden Penelope Toff Michelle Falconer Michael Hudson John Green J. Simon Kroll Charles Vincent Nick Sevdalis

BACKGROUND AND OBJECTIVE Continued suboptimal measles-mumps-rubella (MMR) vaccine uptake has re-established measles epidemic risk, prompting a UK catch-up campaign in 2008-09 for children who missed MMR doses at scheduled age. Predictors of vaccine uptake during catch-ups are poorly understood, however evidence from routine schedule uptake suggests demographics and attitudes may be central. Thi...

Journal: :Cancer research 2004
Efterpi Papouli Petr Cejka Josef Jiricny

Mismatch repair (MMR) deficiency was reported to increase resistance of mammalian cells to killing by several genotoxic substances. However, although MMR-deficient cells are approximately 100-fold more resistant to killing by S(N)1 type methylating agents than MMR-proficient controls, the sensitivity differences reported for the other agents were typically <2-fold. To test whether these differe...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2015
A M Mahedi Hasan David R F Leach

Defects in DNA mismatch repair (MMR) result in elevated mutagenesis and in cancer predisposition. This disease burden arises because MMR is required to correct errors made in the copying of DNA. MMR is bidirectional at the level of DNA strand polarity as it operates equally well in the 5' to 3' and the 3' to 5' directions. However, the directionality of MMR with respect to the chromosome, which...

2013
Medini Manohar Ghodgaonkar Federico Lazzaro Maite Olivera-Pimentel Mariela Artola-Borán Petr Cejka Martin A. Reijns Andrew P. Jackson Paolo Plevani Marco Muzi-Falconi Josef Jiricny

To improve replication fidelity, mismatch repair (MMR) must detect non-Watson-Crick base pairs and direct their repair to the nascent DNA strand. Eukaryotic MMR in vitro requires pre-existing strand discontinuities for initiation; consequently, it has been postulated that MMR in vivo initiates at Okazaki fragment termini in the lagging strand and at nicks generated in the leading strand by the ...

2006
Frank R. Jirik R. Michael Liskay

The DNA mismatch repair (MMR) system in mammalian cells not only serves to correct base mispairs and other replication errors, but it also influences the cellular response to certain forms of DNA damage. Cells that are deficient in MMR are relatively resistant to alkylatlon damage because, in wild-type cells, the MMR system is thought to promote toxicity @fia futile repair of alkylated mispairs...

Journal: :Journal of the Pediatric Infectious Diseases Society 2015
Maurice A Mufson Clemente Diaz Michael Leonardi Christopher J Harrison Stanley Grogg Antonio Carbayo Simon Carlo-Torres Robert JeanFreau Ana Quintero-Del-Rio Gisele Bautista Michael Povey Christopher Da Costa Ouzama Nicholson Bruce L Innis

BACKGROUND M-M-R(TM)II (MMRII; Merck & Co) is currently the only measles-mumps-rubella (MMR) vaccine licensed in the United States. Another licensed vaccine would reinforce MMR supply. This study assessed the immunogenicity of a candidate vaccine (Priorix(TM), GlaxoSmithKline Vaccines [MMR-RIT]) when used as a first dose among eligible children in the United States. METHODS In this explorator...

Journal: :International Seminars in Surgical Oncology 2007
Chintamani Binita P Jha Vimal Bhandari Anju Bansal Sunita Saxena Dinesh Bhatnagar

BACKGROUND The DNA mismatch repair (MMR) pathway is an important post-replicative repair process. It is involved in the maintenance of genomic stability and MMR genes have therefore been named the proofreaders of replicating DNA. These genes repair the replicative errors of DNA and are thus imperative for genomic stability. The MMR genes have been found to be involved in promoting cytotoxicity,...

Journal: :Journal of autism and developmental disorders 2007
Tokio Uchiyama Michiko Kurosawa Yutaka Inaba

It has been suggested that the measles, mumps, and rubella vaccine (MMR) is a cause of regressive autism. As MMR was used in Japan only between 1989 and 1993, this time period affords a natural experiment to examine this hypothesis. Data on 904 patients with autism spectrum disorders (ASD) were analyzed. During the period of MMR usage no significant difference was found in the incidence of regr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید